The reiteration of a 'Buy' rating by a reputable analyst firm like HC Wainwright & Co. is a positive signal for InflaRx. The maintained price target of $9 indicates the firm's continued confidence in the stock's potential, which could positively influence investor sentiment and potentially drive the stock price up in the short term.